Concepedia

The value of 11C-5-hydroxy-tryptophan positron emission tomography in neuroendocrine tumor diagnosis and management: experience from one center

A. Nikolaou, Dimitrios Thomas, C. Kampanellou, Krystallenia Alexandraki, Lars-Göran Andersson, Anders Sundín, Gregory Kaltsas

Journal of Endocrinological Investigation · 2010 · 23 citations · 13 references

DOIFull text

Open access

Concepts

References

13

Whole-Body 11C-5-Hydroxytryptophan Positron Emission Tomography as a Universal Imaging Technique for Neuroendocrine Tumors: Comparison with Somatostatin Receptor Scintigraphy and Computed Tomography

Håkan Örlefors, Anders Sundin, Ulrike Garske et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 332 citations · Full text

, , +17

Comparison of Somatostatin Analog and Meta-Iodobenzylguanidine Radionuclides in the Diagnosis and Localization of Advanced Neuroendocrine Tumors

Gregory Kaltsas, Márta Korbonits, Emelie Heintz et al. · The Journal of Clinical Endocrinology & Metabolism · 2001 · 260 citations · Full text

, , +17

Improved Staging of Patients With Carcinoid and Islet Cell Tumors With <sup>18</sup>F-Dihydroxy-Phenyl-Alanine and <sup>11</sup>C-5-Hydroxy-Tryptophan Positron Emission Tomography

Klaas Pieter Koopmans, Oliver Neels, Ido P. Kema et al. · Journal of Clinical Oncology · 2008 · 238 citations · Full text

, , +17

Intraindividual comparison of 68Ga-DOTA-TATE and 18F-DOPA PET in patients with well-differentiated metastatic neuroendocrine tumours

Alexander Haug, Christoph J. Auernhammer, Björn Wängler et al. · European Journal of Nuclear Medicine and Molecular Imaging · 2009 · 214 citations

, , +14

Neuroendocrine Tumor Imaging: Can <sup>18</sup>F‐Fluorodeoxyglucose Positron Emission Tomography Detect Tumors with Poor Prognosis and Aggressive Behavior?

Claudio Pasquali, Domenico Rubello, Cosimo Sperti et al. · World Journal of Surgery · 1998 · 161 citations

, , +13